Evidence review

What Are Peptides for Sciatica

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `what-are-peptides-sciatica`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/what-are-peptides-sciatica

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/what-are-peptides-sciatica/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/what-are-peptides-sciatica/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/what-are-peptides-sciatica/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/what-are-peptides-sciatica/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Sciatica

  1. Sciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root.
  2. The nerve is signaling damage/compression; suppressing pain does not uncompress the nerve.

Why BPC-157 might help you

  1. You have Sciatica — breakdown is outpacing repair.
  2. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why TB-500 might help you

  1. You have Sciatica — breakdown is outpacing repair.
  2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

Why ARA-290 might help you

  1. You have Sciatica — breakdown is outpacing repair.
  2. What keeps failing: Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.
  3. What ARA-290 is studied to do: Studied for nerve repair and small-fiber regeneration in neuropathy models.
  4. Therefore for you: If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • BPC-157 → structure / tissue
  • TB-500 → inflammation clearance / repair-cell migration
  • ARA-290 → nerve / innervation

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.44 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Targeting the innate repair receptor to treat neuropathy (source s1)

Reviews human ARA290 neuropathy trials; notes no sciatica-specific data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury (source s2)

2010 rat transection study showing functional and histological gains with BPC-157.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Safety and Efficacy of ARA 290 in Sarcoidosis Patients (source s3)

Human trial data on ARA290 in sarcoid neuropathy.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin β4 Promotes the Recovery of Peripheral Nerve Function (source s4)

2012 mouse study on thymosin beta-4 in sciatic injury.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

What are all the things you use or do to reduce sciatica pain — Reddit, r/Sciatica (source s5)

Example anecdotal report from sciatica subreddit.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →
TB-500: Thymosin Beta-4 · inflammation clearance / repair-cell migration · tb-500
{
  "peptide": "tb-500",
  "regenerative_layer": "inflammation clearance / repair-cell migration",
  "targets_this_degeneration": "Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.",
  "proposed_regeneration": "Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.",
  "evidence_in_ledger": {
    "human_claims": 14,
    "preclinical_claims": 4,
    "anecdote_claims": 74,
    "studies_catalogued": 25
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/tb-500"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and rebuilds it at the same time. When breakdown stays ahead of repair, injury or disease persists. Most drugs block signals such as pain or swelling without rebuilding the tissue that created the signal. TB-500 is studied for repair pathways: i…

Full tb-500 article →
ARA-290: Nerve Repair Peptide · nerve / innervation · ara-290
{
  "peptide": "ara-290",
  "regenerative_layer": "nerve / innervation",
  "targets_this_degeneration": "Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.",
  "proposed_regeneration": "Studied for nerve repair and small-fiber regeneration in neuropathy models.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 1,
    "anecdote_claims": 45,
    "studies_catalogued": 21
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/ara-290"
}

Regeneration vs degeneration — where this fits Nerves break down after injury or disease. Small fiber neuropathy is one case where breakdown outruns repair. Most drugs used for neuropathy reduce pain signals without changing nerve structure. ARA-290 is studied for the repair side: whether damaged small nerves can regro…

Full ara-290 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Sciatica · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 5 sources · swipe →chain 30dcf18b360e · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
No randomized controlled trials test BPC-157, TB-500, or ARA-290 specifically in human sciatica from disc herniation.
sources: s1
preclinical
A 2012 mouse study found thymosin beta-4 improved vascular and nerve function after sciatic injury.
sources: s4
humanlow confidence
ARA-290 increased small nerve fiber density and reduced neuropathic pain in small human trials of sarcoidosis and diabetic neuropathy.
sources: s3
preclinicallow confidence
A 2010 rat study showed BPC-157 improved sciatic nerve healing after transection, with faster axonal regeneration and better functional recovery scores.
sources: s2
anecdotallow confidence
Forum users report trying BPC-157/TB-500/ARA-290 stacks for sciatica with mixed perceived improvements in pain and mobility.
sources: s5
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 21:46
What Are Peptides for Sciatica · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: What Are Peptides for Sciatica
Slug: what-are-peptides-sciatica
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"multi_stack","condition":"Sciatica","condition_key":"sciatica","primary_peptide":null,"peptides_in_scope":[{"id":"bpc-157","name":"BPC-157"},{"id":"tb-500","name":"TB-500"},{"id":"ara-290","name":"ARA-290"}],"drugs_in_scope":[],"weight_sensitive":true,"stimulant_context":f
it output
{
  "slug": "what-are-peptides-sciatica",
  "title": "What Are Peptides for Sciatica",
  "body": "## What's breaking down if you have Sciatica\n\nSciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root.\n\nThe nerve is signaling damage/compression; suppressing pain does not uncompress the nerve.\n\nBreakdown outruns repair in multiple layers. Mechanical compression from disc material or narrowed space irritates or damages the nerve root. Blood flow to the area drops. Collagen and tissue structure around the nerve weaken. Repair cells struggle to reach the site. Inflammation lingers without clearing. Nerve fibers themselves lose small-fiber density and send persistent pain signals.\n\nEach layer can keep the problem active even if one improves. Repair-focused approaches target the layers that lag behind.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n
741b9b378cd6573d
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No randomized controlled trials test BPC-157, TB-500, or ARA-290 specifically in human sciatica from disc herniation."?
ask what-are-peptides-sciatica claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2012 mouse study found thymosin beta-4 improved vascular and nerve function after sciatic injury."?
ask what-are-peptides-sciatica claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "ARA-290 increased small nerve fiber density and reduced neuropathic pain in small human trials of sarcoidosis and diabetic neuropathy."?
ask what-are-peptides-sciatica claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2010 rat study showed BPC-157 improved sciatic nerve healing after transection, with faster axonal regeneration and better functional reco…"?
ask what-are-peptides-sciatica claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Forum users report trying BPC-157/TB-500/ARA-290 stacks for sciatica with mixed perceived improvements in pain and mobility."?
ask what-are-peptides-sciatica claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example anecdotal report from sciatica subreddit."
ask what-are-peptides-sciatica source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about What Are Peptides for Sciatica — and what would you need me to tell you first?
ask what-are-peptides-sciatica condition gaps · paste includes §SELF
What good and bad outcomes are documented for What Are Peptides for Sciatica (studies vs anecdotes)?
ask what-are-peptides-sciatica good bad experiences · paste includes §SELF
what-are-peptides-sciatica · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 0 tokens · $0 · 1 model
chain head edf52376d3c059c6
write grok/grok-4.3 · 2026-06-29 21:46 · 0 tok · edf52376d3c0
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 21:46
webhook_in blooio · 2026-06-29 21:46
PROTOCOL_RUN dispatch · 2026-06-29 21:46 · t_kbfvdyvc
PROTOCOL_RUN dispatch · 2026-06-29 21:46 · t_kbfvdyvc
webhook_in blooio · 2026-06-29 21:46
webhook_in blooio · 2026-06-29 21:46
view full ledger & cards →
REST + ledger
read GET /api/articles/what-are-peptides-sciatica · GET /api/articles/what-are-peptides-sciatica?format=post (the editable body)
create/replace POST /api/articles/what-are-peptides-sciatica · PUT /api/articles/what-are-peptides-sciatica (replace, keeps revision) · PATCH /api/articles/what-are-peptides-sciatica (merge)
delete DELETE /api/articles/what-are-peptides-sciatica
writes need header x-terminal-key
LLM bundle GET /api/articles/what-are-peptides-sciatica/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim what-are-peptides-sciatica|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →